TO

tooluniverse-disease-research

A research assistant that gathers and summarizes scientific data on diseases into formatted markdown reports.

Install

mkdir -p .claude/skills/tooluniverse-disease-research && curl -L -o skill.zip "https://agentskills.codes/api/skills/download/9380" && unzip -o skill.zip -d .claude/skills/tooluniverse-disease-research && rm skill.zip

Installs to .claude/skills/tooluniverse-disease-research

Activation

This is the description your AI agent reads to decide when to run this skill — the better it matches your request, the more reliably it fires.

Generate comprehensive disease research reports covering genetics (causal genes, GWAS, OMIM), pathways (Reactome, KEGG), drugs (existing therapies, repurposing candidates), clinical trials, epidemiology (prevalence, incidence), and phenotypes (HPO). Use for full disease overviews, comprehensive disease characterization, and orphan/rare-disease profiling.
356 chars✓ has a “when” triggerlonger than Claude Code's old 250-char listing cap (fine on current versions)
Intermediate

Key capabilities

  • Generate disease research reports
  • Map free text to ontology IDs
  • Trace pathogenic cascades
  • Compile multi-dimensional medical data
  • Cite source references

How it works

It follows a report-first approach, researching 10 dimensions of disease data using specialized tools and updating a markdown file progressively.

Inputs & outputs

You give it
Disease name or medical condition
You get back
Markdown research report with citations

When to use tooluniverse-disease-research

  • Profiling rare diseases
  • Identifying causal genes for specific conditions
  • Researching therapy candidates and pathways

About this skill

ToolUniverse Disease Research

Generate a comprehensive disease research report with full source citations. The report is created as a markdown file and progressively updated during research.

IMPORTANT: Always use English disease names and search terms in tool calls. Respond in the user's language.


LOOK UP, DON'T GUESS

When asked about a disease, query Orphanet/OMIM/DisGeNET FIRST. Don't rely on memory for prevalence, genetics, or treatment — these change over time. When you're not sure about a fact, your first instinct should be to SEARCH for it using tools, not to reason harder from memory.


When to Use

  • User asks about any disease, syndrome, or medical condition
  • Needs comprehensive disease intelligence or a detailed research report
  • Asks "what do we know about [disease]?"

Core Workflow: Report-First Approach

DO NOT show the search process to the user. Instead:

  1. Create report file first - Initialize {disease_name}_research_report.md
  2. Research each dimension - Use all relevant tools
  3. Update report progressively - Write findings after each dimension
  4. Include citations - Every fact must reference its source tool

Disease Mechanism Reasoning

When synthesizing disease etiology, trace the full pathogenic cascade:

  1. Genetic basis - Which variants (rare or common) confer risk, and in which genes?
  2. Molecular mechanism - How do those variants alter protein function, expression, or regulation?
  3. Cellular effect - What downstream cellular processes are disrupted (signaling, metabolism, stress response)?
  4. Tissue/organ manifestation - How does cellular dysfunction present as organ-level pathology?

This chain structures the Genetic & Molecular Basis (Section 3) and Biological Pathways (Section 5) sections.


10 Research Dimensions

DimSectionKey Tools
1Identity & ClassificationOSL_get_efo_id_by_disease_name, ols_search_efo_terms, ols_get_efo_term, umls_search_concepts, icd_search_codes, snomed_search_concepts
2Clinical PresentationOpenTargets phenotypes, HPO lookup, MedlinePlus
3Genetic & Molecular BasisOpenTargets targets, ClinVar variants, GWAS associations, gnomAD
4Treatment LandscapeOpenTargets drugs, clinical trials, GtoPdb
5Biological PathwaysReactome pathways, humanbase_ppi_analysis, GTEx expression, HPA
6Epidemiology & LiteraturePubMed, OpenAlex, Europe PMC, Semantic Scholar
7Similar DiseasesOpenTargets similar entities
8Cancer-Specific (if applicable)CIViC genes/variants/therapies
9PharmacologyGtoPdb targets/interactions/ligands
10Drug SafetyOpenTargets warnings, clinical trial AEs, FAERS

See: tool_usage_details.md for complete tool calls per section.

Normalizing free text to ontology IDs (Dimension 1)

When the input is messy free text (a sample attribute, a synonym, a tissue/organism label) rather than a clean disease name, use ZOOMA_annotate_text to map it to standardized ontology terms (EFO/MONDO/UBERON/etc.) before lookup. It returns each match as an ontology IRI with a confidence rating (HIGH/GOOD/MEDIUM/LOW), so you can keep only high-confidence hits and feed the resolved ID into OLS / OpenTargets.

tu.run_tool("ZOOMA_annotate_text", {
    "property_value": "asthma",        # free text to resolve
    "property_type": "disease",         # optional context hint
    "min_confidence": "HIGH",           # drop fuzzy matches
    "max_results": 3,
})
# -> [{"semantic_tags": ["http://purl.obolibrary.org/obo/MONDO_0004979"],
#      "curies": ["MONDO:0004979"], "confidence": "HIGH", "source": "zooma", ...}]

# Restrict to one ontology source (e.g. EFO) when you need a specific namespace:
tu.run_tool("ZOOMA_annotate_text", {"property_value": "diabetes", "ontologies": "efo"})

# Inspect which curated datasources back ZOOMA annotations (for provenance):
tu.run_tool("ZOOMA_list_datasources", {})
# -> [{"name": "eva-clinvar", "type": "DATABASE", "uri": "https://www.ebi.ac.uk/eva"}, ...]

Each match also carries a ready-to-use curies field (e.g. MONDO:0004979) so you can feed the resolved ID straight into OLS / OpenTargets without parsing the IRI. ZOOMA is the live replacement for the retired OxO cross-reference service; pair it with ols_get_efo_term to expand the resolved IRI into labels, synonyms, and hierarchy.


Report Template

Create this file structure at the start:

# Disease Research Report: {Disease Name}

**Report Generated**: {date}
**Disease Identifiers**: (to be filled)

---

## Executive Summary
(Brief 3-5 sentence overview - fill after all research complete)

---

## 1. Disease Identity & Classification
### Ontology Identifiers
| System | ID | Source |

### Synonyms & Alternative Names
### Disease Hierarchy

---

## 2. Clinical Presentation
### Phenotypes (HPO)
| HPO ID | Phenotype | Description | Source |

### Symptoms & Signs
### Diagnostic Criteria

---

## 3. Genetic & Molecular Basis
### Associated Genes
| Gene | Score | Ensembl ID | Evidence | Source |

### GWAS Associations
| SNP | P-value | Odds Ratio | Study | Source |

### Pathogenic Variants (ClinVar)

---

## 4. Treatment Landscape
### Approved Drugs
| Drug | ChEMBL ID | Mechanism | Phase | Target | Source |

### Clinical Trials
| NCT ID | Title | Phase | Status | Source |

---

## 5. Biological Pathways & Mechanisms

## 6. Epidemiology & Risk Factors

## 7. Literature & Research Activity

## 8. Similar Diseases & Comorbidities

## 9. Cancer-Specific Information (if applicable)

## 10. Drug Safety & Adverse Events

---

## References
### Tools Used
| # | Tool | Parameters | Section | Items Retrieved |

Citation Format

Every piece of data MUST include its source:

In tables: Add a Source column with tool name In lists: - Finding [Source: tool_name] In prose: (Source: tool_name, query: "...") References section: Complete tool usage log with parameters


Progressive Update Pattern

# After each dimension's research:
# 1. Read current report
# 2. Replace placeholder with formatted content
# 3. Write back immediately
# 4. Continue to next dimension

Evidence Grading & Interpretation

Every finding in the report should be graded:

GradeCriteriaExample
T1 (Strong)Replicated genetic evidence (GWAS, rare variants), FDA-approved therapyBRCA1 → breast cancer; trastuzumab for HER2+
T2 (Moderate)Single genetic study, phase II+ trial data, strong biological evidenceFOXO3 → longevity (centenarian studies)
T3 (Association)Observational data, gene expression changes, pathway membershipIL-6 elevated in Alzheimer's CSF
T4 (Computational)Network proximity, text mining, predicted associationsDisGeNET text-mined gene-disease link

Synthesis Questions (answer in Executive Summary)

After collecting data from all 10 dimensions, the report MUST answer:

  1. What causes this disease? Summarize the genetic architecture (monogenic vs polygenic, key loci, penetrance)
  2. What are the therapeutic options? Ranked by evidence level and approval status
  3. What biomarkers exist? For diagnosis, prognosis, and treatment selection
  4. What's the unmet need? What aspects lack effective treatment or understanding?
  5. What are the active research frontiers? Based on clinical trials and recent publications

Interpreting Cross-Database Concordance

When multiple databases provide different data for the same disease:

  • OpenTargets + DisGeNET + OMIM agree on a gene: T1 evidence — high confidence
  • Only OpenTargets reports an association: Check the datasource scores — genetic_association > literature > animal_model
  • DisGeNET score > 0.5 but not in OpenTargets: May be text-mined; verify with PubMed
  • Gene in GWAS but not OMIM: Likely a complex disease susceptibility locus, not Mendelian

Handling Conflicting Data

ConflictResolution
Different prevalence estimates across sourcesReport range; note the most recent/largest study
Drug approved in one country but not anotherNote regulatory status per region
Gene-disease association in one DB but absent in anotherGrade by evidence type; text-mining alone is T4
Clinical trial results contradict label indicationsThe trial result is newer evidence; note both

Final Report Quality Checklist

  • All 10 sections have content (or marked "No data available")
  • Every data point has a source citation
  • Executive summary reflects key findings
  • References section lists all tools used
  • Tables properly formatted
  • No placeholder text remains

Expected Output Scale

For a well-studied disease (e.g., Alzheimer's), the final report should include:

  • 5+ ontology IDs, 10+ synonyms, disease hierarchy
  • 20+ phenotypes with HPO IDs
  • 50+ genes, 30+ GWAS associations, 100+ ClinVar variants
  • 20+ drugs, 50+ clinical trials
  • 10+ pathways, PPI network, expression data
  • 100+ publications
  • 15+ similar diseases
  • Drug warnings and adverse events

Total: 500+ individual data points, each with source citation.


Cross-Skill References

For rare disease differential diagnosis, run: python3 skills/tooluniverse-rare-disease-diagnosis/scripts/clinical_patterns.py --type differential --symptoms 'symptom1,symptom2'


Reference Files


Content truncated.

When not to use it

  • When the disease name is unknown
  • When manual reasoning is preferred over tool-based search

Limitations

  • Requires English search terms
  • Conflicting data requires manual resolution

How it compares

It enforces a systematic, citation-backed research process instead of relying on internal knowledge or unverified search results.

Compared to similar skills

tooluniverse-disease-research side by side with the closest alternatives in the catalog.

SkillInstallsUpdatedSafetyDifficulty
tooluniverse-disease-research (this skill)02moNo flagsIntermediate
paperlab_reproducibility_capsule01moNo flagsIntermediate
knowledge-research02moReviewBeginner
literature-review5592moReviewAdvanced

Try saying

Example prompts that trigger this skill in your AI assistant.

More by mims-harvard

View all by mims-harvard

tooluniverse-drug-research

mims-harvard

Generates comprehensive drug research reports with compound disambiguation, evidence grading, and mandatory completeness sections. Covers identity, chemistry, pharmacology, targets, clinical trials, safety, pharmacogenomics, and ADMET properties. Use when users ask about drugs, medications, therapeutics, or need drug profiling, safety assessment, or clinical development research.

323

tooluniverse-pharmacovigilance

mims-harvard

Analyze drug safety signals from FDA adverse event reports, label warnings, and pharmacogenomic data. Calculates disproportionality measures (PRR, ROR), identifies serious adverse events, assesses pharmacogenomic risk variants. Use when asked about drug safety, adverse events, post-market surveillance, or risk-benefit assessment.

323

tooluniverse-precision-oncology

mims-harvard

Provide actionable treatment recommendations for cancer patients based on molecular profile. Interprets tumor mutations, identifies FDA-approved therapies, finds resistance mechanisms, matches clinical trials. Use when oncologist asks about treatment options for specific mutations (EGFR, KRAS, BRAF, etc.), therapy resistance, or clinical trial eligibility.

321

tooluniverse-expression-data-retrieval

mims-harvard

Retrieves gene expression and omics datasets from ArrayExpress and BioStudies with gene disambiguation, experiment quality assessment, and structured reports. Creates comprehensive dataset profiles with metadata, sample information, and download links. Use when users need expression data, omics datasets, or mention ArrayExpress (E-MTAB, E-GEOD) or BioStudies (S-BSST) accessions.

217

tooluniverse-literature-deep-research

mims-harvard

Conduct comprehensive literature research with target disambiguation, evidence grading, and structured theme extraction. Creates a detailed report with mandatory completeness checklist, biological model synthesis, and testable hypotheses. For biological targets, resolves official IDs (Ensembl/UniProt), synonyms, naming collisions, and gathers expression/pathway context before literature search. Default deliverable is a report file; for single factoid questions, uses a fast verification mode and may include an inline answer. Use when users need thorough literature reviews, target profiles, or to verify specific claims from the literature.

213

tooluniverse-target-research

mims-harvard

Gather comprehensive biological target intelligence from 9 parallel research paths covering protein info, structure, interactions, pathways, expression, variants, drug interactions, and literature. Features collision-aware searches, evidence grading (T1-T4), explicit Open Targets coverage, and mandatory completeness auditing. Use when users ask about drug targets, proteins, genes, or need target validation, druggability assessment, or comprehensive target profiling.

25

You might also like

paperlab_reproducibility_capsule

equinor

|

00

knowledge-research

AliceNN-ucdenver

Read the merged research-doc.md for an OKR. Returns structured findings (R-N anchors) for the PRD agent to cite.

00

literature-review

K-Dense-AI

Conduct comprehensive, systematic literature reviews using multiple academic databases (PubMed, arXiv, bioRxiv, Semantic Scholar, etc.). This skill should be used when conducting systematic literature reviews, meta-analyses, research synthesis, or comprehensive literature searches across biomedical, scientific, and technical domains. Creates professionally formatted markdown documents and PDFs with verified citations in multiple citation styles (APA, Nature, Vancouver, etc.).

5591,298

openalex-database

davila7

Query and analyze scholarly literature using the OpenAlex database. This skill should be used when searching for academic papers, analyzing research trends, finding works by authors or institutions, tracking citations, discovering open access publications, or conducting bibliometric analysis across 240M+ scholarly works. Use for literature searches, research output analysis, citation analysis, and academic database queries.

48202

market-research-reports

davila7

Generate comprehensive market research reports (50+ pages) in the style of top consulting firms (McKinsey, BCG, Gartner). Features professional LaTeX formatting, extensive visual generation with scientific-schematics and generate-image, deep integration with research-lookup for data gathering, and multi-framework strategic analysis including Porter's Five Forces, PESTLE, SWOT, TAM/SAM/SOM, and BCG Matrix.

38162

scientific-brainstorming

davila7

Research ideation partner. Generate hypotheses, explore interdisciplinary connections, challenge assumptions, develop methodologies, identify research gaps, for creative scientific problem-solving.

37155

Search skills

Search the agent skills registry